Pharma's niche focus spurs US aid for antibiotics
(AP) -- The pharmaceutical industry won approval to market a record number of new drugs for rare diseases last year, as a combination of scientific innovation and business opportunity spurred new treatments for diseases long-ignored by drug companies....
Source: PhysOrg - Wednesday, 25 January
Related articles:
- Older News
- 4Vote! Target: Drug-resistant bacteria
PhysOrg - Friday, 4 May
- 3Vote! Analysis - Biotech targets fight back as Big Pharma circles
Yahoo Science News - Wednesday, 2 May
- 3Vote! Biotech targets fight back as Big Pharma circles
- 4Vote! Pinpointing how antibiotics work
- 6Vote! FDA Launches Voluntary Plan To Reduce Use Of Antibiotics In Animals
LabSpaces - Thursday, 12 April
- 6Vote! FDA wants limits on antibiotics given to animals
- 6Vote! Hold the Knife: Antibiotics May Be Safe Treatment for Appendicitis
- 4Vote! Toward a Drug-Free Burger: Ruling May Curb Antibiotics in Meat
- 17Vote! Science & the Public: Growth-promoting antibiotics: On the way out?
ScienceNews - Saturday, 24 March
- 15Vote! FDA must act to cut antibiotics from animal feed
- 14Vote! Food for Thought: Growth-promoting antibiotics: Will they go bye-bye?
- 5Vote! New way to tap largest remaining treasure trove of potential new antibiotics
- 3Vote! Dating sites become mainstream and focus on more niche markets
- 3Vote! Antibiotics won’t cure sinus infections
Futurity.org - Friday, 17 February
- 7Vote! Antibiotics ineffective for most sinus infections
e! Science News - Wednesday, 15 February
- 5Vote! Study: Antibiotics ineffective for most sinus infections
- 11Vote! Pharma's Niche Focus Spurs US Aid for Antibiotics -- The Associated Press
Harvard World Health News - Friday, 27 January
- 10Vote! Fed antibiotics, pigs carry resistant bugs
- 12Vote! Research provides new insights into antibiotics and pig feeds
- 11Vote! FDA bans use of popular antibiotics in animals
